Physician

Alicia R Notkin, MD

According to 2025 Medicare claims, Alicia Notkin, MD (NPI: 1346428950) practices nephrology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is EXCELCARE MEDICAL ASSOCIATES, PA (NPI: 1992736300; TIN: 203130405) and primary practice location at 07503-2621. Notkin is affiliated with the Vytalize Health Enhanced ACO LLC (ACO ID: A5300), participating under the MSSP model.

Notkin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 288 traditional Medicare patients, billed 956 HCPCS/CPT codes, and received $87,348 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 881 prescription claims across 147 beneficiaries totaling $97,381 in drug costs, led by Veltassa (Patiromer Calcium Sorbitex). Open Payments data shows 3 records totaling $272. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $251,113 to $87,348. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $168,098 and ending at $97,381. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	903	2,880	$251,113
2016	801	3,043	$336,887
2017	718	2,576	$223,357
2018	695	2,142	$219,844
2019	566	1,663	$147,268
2020	424	1,470	$137,535
2021	345	1,132	$109,999
2022	364	1,206	$107,255
2023	395	1,131	$99,509
2024	288	956	$87,348

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	159	723	$168,098
2016	124	543	$98,371
2017	89	347	$63,974
2018	115	579	$63,664
2019	142	791	$58,646
2020	125	687	$79,269
2021	131	598	$75,517
2022	133	779	$89,761
2023	138	799	$152,513
2024	147	881	$97,381

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	37	39	$139
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	67	71	$107
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	67	118	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	48	95	$89
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	176	487	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Veltassa	Patiromer Calcium Sorbitex	23	864	$25,842
Procrit	Epoetin Alfa	14	398	$23,123
Januvia	Sitagliptin Phosphate	20	780	$14,351
Sevelamer Carbonate	Sevelamer Carbonate	19	1,230	$2,569
Hydralazine Hcl	Hydralazine Hcl	96	7,095	$1,369

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$272	Aurinia Pharma U.S., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alicia R. Notkin, MD?

Tedicare shows public-source Medicare data for Alicia R. Notkin, MD (NPI 1346428950), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alicia R. Notkin, MD have ACO affiliation data?

Alicia R. Notkin, MD is shown with ACO affiliation data for Vytalize Health Enhanced ACO LLC (MSSP, ACO ID A5300).

What billing organization is linked to Alicia R. Notkin, MD?

Alicia R. Notkin, MD is linked to EXCELCARE MEDICAL ASSOCIATES, PA (billing NPI 1992736300) in the available physician profile data.

Does Alicia R. Notkin, MD have Open Payments data?

Alicia R. Notkin, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.